| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 20 | 2023 | 165 | 3.870 |
Why?
|
| Myocardial Reperfusion Injury | 9 | 2021 | 54 | 3.330 |
Why?
|
| Glycogen | 8 | 2021 | 17 | 2.090 |
Why?
|
| Reperfusion Injury | 3 | 2023 | 53 | 1.640 |
Why?
|
| Heart | 7 | 2021 | 178 | 1.440 |
Why?
|
| Cell Death | 7 | 2023 | 260 | 1.430 |
Why?
|
| Myocardium | 16 | 2017 | 224 | 1.430 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 221 | 1.300 |
Why?
|
| Physical Endurance | 2 | 2021 | 18 | 1.190 |
Why?
|
| Iron | 3 | 2022 | 204 | 1.170 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2005 | 229 | 1.070 |
Why?
|
| Cardiomegaly | 4 | 2011 | 39 | 1.040 |
Why?
|
| Physical Conditioning, Animal | 3 | 2016 | 26 | 0.960 |
Why?
|
| Animals | 45 | 2023 | 14307 | 0.950 |
Why?
|
| Heart Injuries | 1 | 2023 | 11 | 0.950 |
Why?
|
| Insulin | 5 | 2021 | 224 | 0.950 |
Why?
|
| Brain | 3 | 2021 | 1268 | 0.940 |
Why?
|
| Lactic Acid | 4 | 2021 | 87 | 0.930 |
Why?
|
| Signal Transduction | 16 | 2019 | 1802 | 0.930 |
Why?
|
| Blood Glucose | 4 | 2021 | 333 | 0.890 |
Why?
|
| Cell Survival | 7 | 2019 | 818 | 0.860 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 628 | 0.860 |
Why?
|
| Heart Failure | 6 | 2022 | 230 | 0.840 |
Why?
|
| Ventricular Remodeling | 4 | 2022 | 59 | 0.830 |
Why?
|
| Calcium Signaling | 2 | 2021 | 95 | 0.810 |
Why?
|
| Hypoglycemia | 1 | 2021 | 17 | 0.790 |
Why?
|
| Polyketide Synthases | 2 | 2017 | 7 | 0.750 |
Why?
|
| Apoptosis | 16 | 2022 | 1317 | 0.740 |
Why?
|
| Quinolones | 2 | 2017 | 7 | 0.740 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 12 | 0.710 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 50 | 0.700 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2019 | 592 | 0.700 |
Why?
|
| Cell Division | 4 | 2007 | 296 | 0.670 |
Why?
|
| Mice | 24 | 2023 | 5668 | 0.670 |
Why?
|
| G2 Phase | 2 | 2007 | 25 | 0.630 |
Why?
|
| Osteosarcoma | 2 | 2007 | 24 | 0.630 |
Why?
|
| Evodia | 1 | 2017 | 2 | 0.620 |
Why?
|
| Bone Neoplasms | 2 | 2007 | 42 | 0.610 |
Why?
|
| Myocardial Ischemia | 5 | 2012 | 72 | 0.610 |
Why?
|
| Alkaloids | 1 | 2017 | 38 | 0.590 |
Why?
|
| Plants, Medicinal | 1 | 2017 | 54 | 0.590 |
Why?
|
| Mice, Transgenic | 9 | 2017 | 608 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2006 | 245 | 0.580 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 147 | 0.570 |
Why?
|
| Plant Proteins | 1 | 2017 | 93 | 0.570 |
Why?
|
| Heart Diseases | 1 | 2017 | 99 | 0.560 |
Why?
|
| Adenoviridae | 9 | 2019 | 59 | 0.550 |
Why?
|
| Rats | 18 | 2021 | 3261 | 0.530 |
Why?
|
| Biomedical Research | 1 | 2019 | 371 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 1530 | 0.500 |
Why?
|
| Guanosine Triphosphate | 1 | 2013 | 15 | 0.490 |
Why?
|
| Gene Transfer Techniques | 3 | 2003 | 43 | 0.460 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 80 | 0.450 |
Why?
|
| Protein Multimerization | 1 | 2013 | 97 | 0.450 |
Why?
|
| Male | 21 | 2023 | 18870 | 0.450 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 97 | 0.450 |
Why?
|
| Humans | 32 | 2023 | 34853 | 0.430 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2009 | 88 | 0.420 |
Why?
|
| Thiocyanates | 2 | 2010 | 6 | 0.420 |
Why?
|
| Time Factors | 5 | 2021 | 1681 | 0.410 |
Why?
|
| Receptors, IgE | 2 | 2008 | 22 | 0.400 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 54 | 0.390 |
Why?
|
| Rats, Wistar | 3 | 2021 | 202 | 0.390 |
Why?
|
| Glucose | 2 | 2016 | 217 | 0.380 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 1300 | 0.370 |
Why?
|
| Hippocampus | 3 | 2019 | 546 | 0.360 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 520 | 0.340 |
Why?
|
| Cell Degranulation | 1 | 2008 | 10 | 0.340 |
Why?
|
| Receptors, Fc | 1 | 2008 | 7 | 0.340 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 33 | 0.330 |
Why?
|
| Antigens, CD | 1 | 2008 | 116 | 0.320 |
Why?
|
| Indole Alkaloids | 1 | 2007 | 12 | 0.320 |
Why?
|
| Sp1 Transcription Factor | 2 | 2007 | 44 | 0.320 |
Why?
|
| Interleukin-6 | 2 | 2023 | 140 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 1 | 2007 | 65 | 0.300 |
Why?
|
| Quinolines | 1 | 2007 | 60 | 0.300 |
Why?
|
| Muscle, Skeletal | 5 | 2021 | 257 | 0.300 |
Why?
|
| Obesity | 1 | 2015 | 965 | 0.300 |
Why?
|
| Cells, Cultured | 11 | 2017 | 1442 | 0.300 |
Why?
|
| Gene Targeting | 2 | 2005 | 39 | 0.300 |
Why?
|
| Necrosis | 4 | 2015 | 45 | 0.280 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2007 | 107 | 0.280 |
Why?
|
| Blotting, Western | 6 | 2016 | 834 | 0.270 |
Why?
|
| Transfection | 5 | 2019 | 496 | 0.260 |
Why?
|
| Lipid Peroxidation | 2 | 2022 | 131 | 0.260 |
Why?
|
| Liver | 2 | 2021 | 447 | 0.250 |
Why?
|
| Transgenes | 2 | 2015 | 57 | 0.250 |
Why?
|
| Cicatrix | 1 | 2023 | 17 | 0.240 |
Why?
|
| Mice, Knockout | 5 | 2021 | 897 | 0.230 |
Why?
|
| Interleukin-15 | 1 | 2023 | 13 | 0.230 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 135 | 0.230 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 287 | 0.220 |
Why?
|
| Cardiomyopathies | 1 | 2003 | 55 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 82 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 468 | 0.210 |
Why?
|
| Cell Line | 4 | 2019 | 1289 | 0.210 |
Why?
|
| Crystallography, X-Ray | 3 | 2017 | 237 | 0.200 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2021 | 6 | 0.200 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 522 | 0.190 |
Why?
|
| Cyclic AMP | 1 | 2021 | 125 | 0.190 |
Why?
|
| Fibrosis | 2 | 2012 | 146 | 0.190 |
Why?
|
| Antioxidants | 2 | 2022 | 386 | 0.180 |
Why?
|
| Perfusion | 2 | 2012 | 31 | 0.180 |
Why?
|
| Hydrogen Peroxide | 2 | 2019 | 181 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 184 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 336 | 0.170 |
Why?
|
| Enzyme Activation | 4 | 2005 | 423 | 0.170 |
Why?
|
| Phosphorylation | 5 | 2010 | 878 | 0.170 |
Why?
|
| Gene Silencing | 1 | 2019 | 143 | 0.170 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 416 | 0.160 |
Why?
|
| Ubiquitin | 1 | 2019 | 76 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 484 | 0.160 |
Why?
|
| Ligation | 2 | 2012 | 9 | 0.160 |
Why?
|
| Phenylenediamines | 1 | 2017 | 8 | 0.160 |
Why?
|
| Astrocytes | 2 | 2016 | 203 | 0.160 |
Why?
|
| Cyclohexylamines | 1 | 2017 | 12 | 0.160 |
Why?
|
| Annexin A5 | 2 | 2009 | 24 | 0.160 |
Why?
|
| Carbolines | 1 | 2017 | 13 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2018 | 46 | 0.160 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 550 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 901 | 0.150 |
Why?
|
| Ferric Compounds | 1 | 2017 | 49 | 0.150 |
Why?
|
| Coronary Vessels | 2 | 2012 | 93 | 0.150 |
Why?
|
| Contrast Media | 2 | 2009 | 95 | 0.150 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2016 | 9 | 0.150 |
Why?
|
| Piperazines | 1 | 2017 | 109 | 0.150 |
Why?
|
| Mutagenesis | 2 | 2013 | 87 | 0.150 |
Why?
|
| Inflammation | 2 | 2012 | 577 | 0.150 |
Why?
|
| Colonic Neoplasms | 2 | 2010 | 181 | 0.150 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 13 | 0.140 |
Why?
|
| Tissue Fixation | 1 | 2016 | 18 | 0.140 |
Why?
|
| Radiology | 1 | 2016 | 10 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 383 | 0.140 |
Why?
|
| Symporters | 2 | 2006 | 11 | 0.140 |
Why?
|
| Anatomy | 1 | 2016 | 24 | 0.140 |
Why?
|
| Genetic Vectors | 6 | 2015 | 154 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2010 | 1152 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 756 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2016 | 66 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 160 | 0.130 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 8 | 0.130 |
Why?
|
| DNA | 2 | 2012 | 549 | 0.130 |
Why?
|
| Insulin Resistance | 2 | 2015 | 177 | 0.130 |
Why?
|
| Memory | 1 | 2016 | 165 | 0.130 |
Why?
|
| Aspergillus oryzae | 1 | 2015 | 1 | 0.130 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 47 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 42 | 0.130 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 32 | 0.130 |
Why?
|
| Cancer Vaccines | 1 | 2015 | 21 | 0.130 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 274 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 104 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2005 | 27 | 0.120 |
Why?
|
| Fungal Proteins | 1 | 2015 | 130 | 0.120 |
Why?
|
| Weight Gain | 1 | 2015 | 128 | 0.120 |
Why?
|
| Hypertrophy | 2 | 2005 | 31 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 61 | 0.120 |
Why?
|
| Acridones | 1 | 2013 | 1 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 120 | 0.120 |
Why?
|
| Hydrolysis | 1 | 2013 | 86 | 0.120 |
Why?
|
| Osteopontin | 1 | 2013 | 35 | 0.120 |
Why?
|
| Exercise | 1 | 2019 | 524 | 0.120 |
Why?
|
| Acyltransferases | 1 | 2013 | 21 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2005 | 167 | 0.120 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 172 | 0.120 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2016 | 15 | 0.110 |
Why?
|
| Citrate (si)-Synthase | 1 | 2011 | 12 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2012 | 115 | 0.100 |
Why?
|
| Microwaves | 1 | 2011 | 26 | 0.100 |
Why?
|
| Sulfoxides | 2 | 2010 | 16 | 0.100 |
Why?
|
| Isothiocyanates | 2 | 2010 | 18 | 0.100 |
Why?
|
| Ventricular Myosins | 1 | 2011 | 1 | 0.100 |
Why?
|
| Luciferases | 2 | 2010 | 62 | 0.100 |
Why?
|
| Myocarditis | 1 | 2011 | 17 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 605 | 0.100 |
Why?
|
| Autophagy | 1 | 2012 | 111 | 0.100 |
Why?
|
| Exercise Test | 1 | 2011 | 68 | 0.100 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2009 | 126 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2011 | 52 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2128 | 0.100 |
Why?
|
| Monophenol Monooxygenase | 1 | 2010 | 11 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 66 | 0.090 |
Why?
|
| Skin Pigmentation | 1 | 2010 | 18 | 0.090 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2009 | 12 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2010 | 93 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 30 | 0.090 |
Why?
|
| Prostaglandin D2 | 1 | 2010 | 26 | 0.090 |
Why?
|
| Melanins | 1 | 2010 | 32 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 34 | 0.090 |
Why?
|
| Plasmids | 2 | 2016 | 233 | 0.090 |
Why?
|
| Carbocyanines | 1 | 2009 | 14 | 0.090 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 20 | 0.090 |
Why?
|
| Risk Factors | 1 | 2018 | 3414 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 649 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 53 | 0.090 |
Why?
|
| Monocytes | 2 | 2002 | 258 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2009 | 49 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 251 | 0.090 |
Why?
|
| Iodine Radioisotopes | 2 | 2006 | 33 | 0.090 |
Why?
|
| Thiazolidines | 1 | 2008 | 4 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2006 | 1534 | 0.080 |
Why?
|
| Female | 7 | 2023 | 19873 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2011 | 628 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2009 | 121 | 0.080 |
Why?
|
| Actins | 1 | 2008 | 142 | 0.080 |
Why?
|
| Myosin Heavy Chains | 2 | 2011 | 19 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 52 | 0.080 |
Why?
|
| Fasting | 1 | 2007 | 50 | 0.080 |
Why?
|
| NAD | 1 | 2007 | 39 | 0.080 |
Why?
|
| Response Elements | 1 | 2007 | 52 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 183 | 0.080 |
Why?
|
| Rats, Inbred OLETF | 2 | 2016 | 4 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 58 | 0.070 |
Why?
|
| Mitochondria | 2 | 2007 | 454 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 480 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 420 | 0.070 |
Why?
|
| Hexokinase | 1 | 2005 | 9 | 0.070 |
Why?
|
| Deoxyglucose | 1 | 2005 | 19 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 34 | 0.070 |
Why?
|
| Neurons | 3 | 2019 | 1130 | 0.070 |
Why?
|
| Phenotype | 2 | 2013 | 650 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2010 | 1149 | 0.070 |
Why?
|
| Echocardiography | 2 | 2006 | 144 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 200 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 239 | 0.070 |
Why?
|
| Genes, erbB-2 | 1 | 2004 | 6 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2002 | 175 | 0.070 |
Why?
|
| Cell Hypoxia | 2 | 2007 | 55 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 45 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 859 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2005 | 653 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2004 | 85 | 0.060 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2004 | 1 | 0.060 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Sp3 Transcription Factor | 1 | 2004 | 8 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 2004 | 66 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 26 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 26 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2005 | 60 | 0.060 |
Why?
|
| Cytokines | 1 | 2007 | 569 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 2004 | 122 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 121 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 360 | 0.060 |
Why?
|
| Mast Cells | 1 | 2003 | 77 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 164 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2004 | 156 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 81 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 282 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 376 | 0.060 |
Why?
|
| Hela Cells | 1 | 2004 | 344 | 0.060 |
Why?
|
| Gene Expression | 1 | 2005 | 639 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 9 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 47 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 180 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 195 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2001 | 12 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 122 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 600 | 0.050 |
Why?
|
| Cell Count | 1 | 2001 | 129 | 0.050 |
Why?
|
| Phenylephrine | 3 | 2006 | 34 | 0.050 |
Why?
|
| Calcium | 1 | 2003 | 445 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 707 | 0.050 |
Why?
|
| Proteins | 1 | 2003 | 352 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2011 | 43 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 229 | 0.050 |
Why?
|
| Morpholines | 1 | 1999 | 65 | 0.040 |
Why?
|
| Phosphoproteins | 3 | 2005 | 154 | 0.040 |
Why?
|
| Middle Aged | 2 | 2010 | 9642 | 0.040 |
Why?
|
| Chromones | 1 | 1999 | 51 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1999 | 108 | 0.040 |
Why?
|
| Up-Regulation | 3 | 2007 | 490 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2019 | 64 | 0.040 |
Why?
|
| bcl-X Protein | 2 | 2010 | 23 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 396 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2009 | 18 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 391 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 968 | 0.040 |
Why?
|
| Immunoassay | 1 | 2016 | 57 | 0.040 |
Why?
|
| Aged | 2 | 2023 | 6448 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 79 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 2006 | 27 | 0.040 |
Why?
|
| Biological Transport | 1 | 2016 | 175 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 87 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 152 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2006 | 33 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 430 | 0.030 |
Why?
|
| Granzymes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 2015 | 27 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 19 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2015 | 73 | 0.030 |
Why?
|
| Immunization | 1 | 2015 | 90 | 0.030 |
Why?
|
| Body Weight | 1 | 2016 | 404 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 122 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 57 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2015 | 80 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2015 | 112 | 0.030 |
Why?
|
| Myostatin | 2 | 2006 | 57 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 222 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 150 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2005 | 110 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 235 | 0.030 |
Why?
|
| Citrus | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 26 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2013 | 49 | 0.030 |
Why?
|
| Antibodies | 1 | 2013 | 135 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 97 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2004 | 323 | 0.030 |
Why?
|
| Mesothelioma | 1 | 2015 | 135 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2013 | 257 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 310 | 0.030 |
Why?
|
| Kinetics | 1 | 2013 | 650 | 0.030 |
Why?
|
| HLA-DQ Antigens | 1 | 2011 | 6 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 641 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2011 | 8 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 406 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2011 | 61 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 82 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1124 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2003 | 325 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 77 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 269 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
| Arbutin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2010 | 11 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 9 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2010 | 9 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1490 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 612 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2003 | 306 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2009 | 7 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 11 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 751 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 171 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 90 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 106 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 72 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 323 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 932 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 194 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 151 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 871 | 0.020 |
Why?
|
| Methyl Methanesulfonate | 1 | 2007 | 6 | 0.020 |
Why?
|
| Sirtuin 3 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2007 | 7 | 0.020 |
Why?
|
| Sirtuins | 1 | 2007 | 12 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2007 | 30 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1014 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2007 | 135 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 100 | 0.020 |
Why?
|
| Mutagens | 1 | 2007 | 66 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2006 | 20 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 96 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 225 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 132 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 200 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2005 | 18 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2007 | 351 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 19 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2004 | 28 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 48 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2005 | 89 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 55 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 240 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 109 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 106 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2003 | 2 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2003 | 4 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 162 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 8 | 0.020 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2003 | 11 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2005 | 150 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 139 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2003 | 24 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 19 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2005 | 528 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 38 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 72 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2003 | 28 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 555 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2003 | 10 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 57 | 0.010 |
Why?
|
| Comet Assay | 1 | 2003 | 72 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2003 | 14 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2003 | 54 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2003 | 23 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2003 | 33 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 186 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 121 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2003 | 73 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2003 | 72 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 1 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 2002 | 7 | 0.010 |
Why?
|
| E-Selectin | 1 | 2002 | 19 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 27 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 392 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 53 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 170 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 40 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 287 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 209 | 0.010 |
Why?
|
| Temperature | 1 | 2002 | 275 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 298 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 341 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2001 | 82 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 486 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 1023 | 0.010 |
Why?
|
| Adult | 1 | 2009 | 11034 | 0.010 |
Why?
|